Fractyl Health Inc. Common Stock (GUTS)
Stock · NASDAQ · Health Care
$1.55as of 10/16/2026
Price chart
Active signals
GUTS Signal Track Record
How signals performed across all stocks →What GUTS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 19 | -8.0% | 47% | September 23, 2026 |
| Bollinger Band Breakdown | 10 | +5.6% | 60% | September 15, 2026 |
| Bollinger Band Breakout | 10 | -15.8% | 40% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -24.6% | 33% | November 17, 2025 |
| Any 20-session window (baseline) | -4.7% | 41% |
Computed by MarketWall from daily closing prices since November 15, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GUTS
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated vi…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 100
- Website
- www.fractyl.com/
Fundamentals
- 1-day range
- $3.92$4.21
- Market cap
- $108.99M
- P/E (trailing)
- —
- P/E (forward)
- -0.87
- EPS (trailing)
- $-2.07
- Dividend yield
- —
- Beta
- 2.47
- Avg. volume
- 147.5K
How Fractyl Health Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 3, 2025 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
Fractyl Health Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GUTSFractyl Health Inc. Common Stock$1.55▼ 62.74%Market cap $108.99MP/E —$3.78$29.34
- SKINSkinHealth Systems Inc. Class A Common Stock$10.56▼ 16.19%Market cap $99.91MP/E —$10.01$34.8
- MBOTMicrobot Medical Inc. Common Stock$0.95▲ 0.00%Market cap $120.90MP/E —$0.99$3.04
- PYPDPolyPid Ltd. Ordinary Shares$4.72▼ 3.67%Market cap $91.79MP/E —$3.1$5.73
- LUNGPulmonx Corporation Common Stock$1.78▼ 3.78%Market cap $88.04MP/E —$1.13$2.89
- RCELAvita Medical Inc. Common Stock$13.04▼ 2.76%Market cap $146.19MP/E —$3.22$13.73
- LNSRLENSAR Inc. Common Stock$5.8▼ 3.81%Market cap $70.43MP/E 2.15$4.95$12.94
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GUTS Fractyl Health Inc. Common Stock | $108.99M | — | $1.55 | ▼ 62.74% | $3.78$29.34 |
| SKIN SkinHealth Systems Inc. Class A Common Stock | $99.91M | — | $10.56 | ▼ 16.19% | $10.01$34.8 |
| MBOT Microbot Medical Inc. Common Stock | $120.90M | — | $0.95 | ▲ 0.00% | $0.99$3.04 |
| PYPD PolyPid Ltd. Ordinary Shares | $91.79M | — | $4.72 | ▼ 3.67% | $3.1$5.73 |
| LUNG Pulmonx Corporation Common Stock | $88.04M | — | $1.78 | ▼ 3.78% | $1.13$2.89 |
| RCEL Avita Medical Inc. Common Stock | $146.19M | — | $13.04 | ▼ 2.76% | $3.22$13.73 |
| LNSR LENSAR Inc. Common Stock | $70.43M | 2.15 | $5.8 | ▼ 3.81% | $4.95$12.94 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Why Fractyl Health Stock Is Sinking Fridaybenzinga · 10/16/2026
- What's going on in today's after hours sessionChartMill · 10/1/2026
- Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeekingAlpha · 9/14/2026
Insider Activity
Insider Actions →- BRADLEY WILLIAM · September 14, 2026 · Buy64.5K @ $0.6185
- Royan Ajay · June 12, 2026 · Buy23.0K @ $0.852
- Conaway Samuel · June 10, 2026 · Grant22.5K
- Royan Ajay · June 10, 2026 · Grant22.5K
- Thompson Christopher Charles · June 10, 2026 · Grant22.5K
- Elia Marc · June 10, 2026 · Grant22.5K
- Barnes Kelly Ann · June 10, 2026 · Grant22.5K
- Sheffield Ian · June 10, 2026 · Grant22.5K
- Sheffield Ian · June 10, 2026 · Buy35.0K @ $0.7294
- Rajagopalan Harith · June 10, 2026 · Buy25.0K @ $0.7301
- MEANWELL CLIVE · June 10, 2026 · Grant22.5K
- BRADLEY WILLIAM · June 10, 2026 · Grant22.5K
- BRADLEY WILLIAM · June 10, 2026 · Buy68.5K @ $0.7348
- Smith Weber Lara · June 8, 2026 · Buy20.0K @ $0.6854
Institutional Ownership
March 31, 2026
- Total shares held
- 72.79M
- Total value held
- $33.25M
- Institutional holders
- 81
- Unknown13.36M
- Unknown6.73M
- Unknown5.92M
- Unknown5.53M
- Unknown5.49M
- Unknown4.88M
- Unknown4.77M
- Unknown3.97M
- Unknown2.24M
- Unknown2.14M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
GUTS after hours trading shows Bollinger Band breakdown
After hours trading for GUTS showed a breakdown of the Bollinger Bands and a high beta signal, suggesting increased volatility. The stock is near its support level at $0.76, with an RSI of 33.0 indicating it is not overbought. This activity may keep the price near the lower end of its 52‑week range. The market is watching how the stock reacts to this volatility.
GUTS after hours trading shows Bollinger Band breakdown. After hours trading for GUTS showed a breakdown of the Bollinger Bands and a high beta signal, suggesting increased volatility. The stock is near its support level at $0.76, with an RSI of 33.0 indicating it is not overbought. This activity may keep the price near the lower end of its 52‑week range. The market is watching how the stock reacts to this volatility.